|4Jan 7, 9:14 AM ET

CAUWENBERGH GEERT 4

4 · Phio Pharmaceuticals Corp. · Filed Jan 7, 2019

Insider Transaction Report

Form 4
Period: 2019-01-04
CAUWENBERGH GEERT
DirectorPresident & CEO
Transactions
  • Award

    Common stock, $0.0001 par value

    2019-01-04$0.35/sh+23,139$8,096261,699 total
Holdings
  • Common stock, $0.0001 par value

    (indirect: By Spouse)
    450
Footnotes (1)
  • [F1]As reported on the Current Report on Form 8-K filed on September 4, 2018 and December 21, 2018, the reporting person has elected to receive a portion of his compensation in stock in lieu of cash. Accordingly, on January 4, 2019, the reporting person received a total of 23,139 shares of common stock from the Company in lieu of $8,096.16 of cash compensation, which includes base salary, that was payable on such date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION